Richard Maurice Walmsley
Gründer bei Gentronix Ltd.
Aktive Positionen von Richard Maurice Walmsley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | - |
| Gründer | 22.03.2010 | - | |
| University of Manchester Institute of Science & Technology | Corporate Officer/Principal | - | - |
Karriereverlauf von Richard Maurice Walmsley
Ausbildung von Richard Maurice Walmsley
| University of Kent | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Gentronix Ltd.
Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
